H1N1 Update 16 December 2010 sent from the UK Intensive Care Society
As many of you will already be aware, the predicted second wave of swine flu seems to becoming a reality. The HPA have received information that there has been a rise in the number of confirmed H1N1 cases and has restarted regular teleconferences to discuss the current situation and to disseminate the latest advice and information. The initial teleconference was held last Friday and the first question asked was how many cases have units seen. Although the total numbers were not high, the fact that there are confirmed cases throughout the UK gave support to the decision that hospitals should prepare for an increase in the numbers.
Subsequent updates have confirmed that the case numbers are rising and although not all patients admitted to ICUs with a suspected diagnosis of H1N1 have required mechanical ventilation or had H1N1 confirmed. As of Wednesday this week the numbers of H1N1 related ICU cases had risen to 140. An additional concern is that the number of cases with probable H1N1 referred for ECMO is now 13 and this has resulted in a policy that there should be support for all the centers in the UK who can provide ECMO.
It is still too early to predict what the level escalation is going to be required, but there are real concerns that the combination of adverse weather conditions, the current financial restrictions in the NHS, and an H1N1 peak could place ICUs in a more seriously challenging situation than occurred in the previous outbreak.
For this reason, it is recommended that clinicians should once again have a low threshold for considering the possibility of H1N1 in patients who are referred to intensive care. Trusts should reconvene regular meetings to plan for any necessary expansion of critical care services. It is important that staff have up to date training in the use of personal protection equipment. One of the most important points learned from the first outbreak was that early antiviral therapy can reduce the need for mechanical ventilation and it is recommended that any patients admitted to hospital with a history and symptoms suggestive of an influenza-like illness should be given antiviral therapy.
The following points were made in the HPA–led teleconference on 10 December:
be vigilant: have a low threshold for considering the diagnosis.
start antivirals whenever there is a suspicion of flu (oseltamivir 75or 150 mg bd po).
In patients with resistance or not tolerating NG medication, there is an IV preparation which is currently undergoing clinical trial. GSK produces it (zanamavir) and may provide it on patient-name compassionate grounds.
Use ARDSnet ventilation especially for those with normal lung compliance.
Consider HFO for those with poor compliance
Fluid restrict patients
Consider referral for ECMO early if conventional ventilation is failing. ECMO beds are occupied almost all occupied by ‘flu patients and elective surgery has been curtailed to accomodate them. Surge funding has been agreed for extra ECMO. In cases where conventional ventilation is failing and there are no other options, patients should be referred to Glenfield before seven days of MV.
There will be advice re pregnant women after discussion with the RCOG
In some cases, URT specimens may be negative in severe cases and LRT samples may be needed for the diagnosis.
Point of care testing may have inadequate sensitivity for this strain of H1N1
The current rate is 21.5/100,000.
We aim to provide updates on the ICS website and copy of this document is available to download via http://www.ics.ac.uk/ under ‘Latest News – H1N1 Latest News’.
Update by the Executive Committee of the Intensive Care Society.
Sent from the email of:
Pauline Kemp
Head of Secretariat
Therapeutic hypothermia (TH) has been associated with improved outcomes in term infants who present with moderate hypoxic-ischaemic encephalopathy (HIE). However, in the three major studies the time to initiate cooling was at approximately 4.5 postnatal hours. Many newborns are referred to specialist centres where cooling takes place from outlying hospitals (‘outborn’). It may be the case that earlier initiation of TH could improve outcomes, leading Takenouchi and colleagues to propose a ‘Chain of Brain Preservation’.
‘Given that most infants are outborn, a time sensitive education metaphor termed Chain of Brain Preservation may facilitate early recognition of high risk infants and thus earlier treatment.‘ Chain of Brain Preservation—A concept to facilitate early identification and initiation of hypothermia to infants at high risk for brain injury Resuscitation. 2010 Dec;81(12):1637-41
Dr WFS Sellers and colleagues describe several cases that demonstrate convincingly a protective effect of intravenous magnesium sulphate against the tachycardia produced by intravenous salbutamol in patients with asthma. This effect was observed both when magnesium was given before and when given after the salbutamol. It was seen in critically ill asthmatic patients and in a volunteer with well-controlled asthma.
Intravenous magnesium sulphate increases atrial contraction time and refractory times. It is used to treat atrial tachyarrhythmias and has a negative chronotropic and dromotropic effect. Intravenous magnesium sulphate prevents intravenous salbutamol tachycardia in asthma Br J Anaesth. 2010 Dec;105(6):869-70
ECG machines may give a printed report saying ***ACUTE MI***. In a retrospective study, patients on the ICU whose 12 lead ECGs contained this electronic interpretation did not have an elevated troponin 85% of the time. Even in the minority of patients whose electronic ECG diagnosis of MI was agreed with by a cardiologist, only one third developed an elevated troponin.
The authors state ‘In contrast to nonintensive care unit patients who present with chest pain, the electrocardiographic ST-segment elevation myocardial infarction diagnosis seems to be a nonspecific finding in the intensive care unit that is frequently the result of a variety of nonischaemic processes. The vast majority of such patients do not have frank ST-segment elevation myocardial infarction.’ Electrocardiographic ST-segment elevation myocardial infarction in critically ill patients: An observational cohort analysis Crit Care Med. 2010 Dec;38(12):2304-230
Given that single-dose etomidate can cause measurable adrenal suppression, its use in patients with sepsis is controversial. A prospective, double-blind, randomised study of patients with suspected sepsis who were intubated in the ED randomised patients to receive either etomidate or midazolam before intubation. The primary outcome measure was hospital length of stay, and no difference was demonstrated. The study was not powered to detect a mortality difference.
This study is interesting as a provider of fuel for the ‘etomidate debate’, but still irrelevant to those of us who have abandoned etomidate in favour of ketamine as an induction agent for haemodynamically unstable patients. Personally I remain unconvinced of the existence of patients who can’t be safely intubated using the limited choice of thiopentone or ketamine. A Comparison of the Effects of Etomidate and Midazolam on Hospital Length of Stay in Patients With Suspected Sepsis: A Prospective, Randomized Study Annals Emergency Medicine 2010;56(5):481-9
Central lines in the ED are more likely to get infected because they’re inserted under less scrupulously aseptic conditions than in ICU, done more urgently, and are more likely to be placed in the mucky old femoral site by clumsy emergency physicians who don’t wash their hands after scratching their arses. Anyway, the intensivists will usually replace them with a ‘more ideal’ line after ICU admission. Right? Well, that’s what’s often taught and assumed to be the case, but a new study from a single centre suggests otherwise. ED-placed central venous catheters (19% of which were femoral) were typically left in for 4 to 5 days. The infection rate was 1.9 per 1,000 catheter-days, similar to that reported for central lines in other ICU case series. Infection and Natural History of Emergency Department–Placed Central Venous Catheters Annals of Emergency Medicine 2010;56(5):492-7
Sugammadex currently has no role in my own emergency / critical care practice. However a helpful paper informs us that patients whose rocuronium-induced neuromuscular blockade had been reversed by sugammadex may be effectively re-paralysed by a second high dose (1.2 mg/kg) of rocuronium. Onset was slower and duration shorter if the second dose of rocuronium was given within 25 minutes of the sugammadex.
The study was done with sixteen volunteers and the initial dose of roc was only 0.6 mg/kg – less than that used for rapid sequence intubation by many emergency & critical care docs.
When repeat dose roc was given five minutes after sugammadex (n=6), mean (SD) onset time maximal block was 3.06 (0.97) min; range, 1.92–4.72 min. For repeat dose time points ≥25 min after sugammadex (n=5), mean onset was faster (1.73 min) than for repeat doses <25 min (3.09 min) after sugammadex. The duration of block ranged from 17.7 min (rocuronium 5 min after sugammadex) to 46 min (repeat dose at 45 min) with mean durations of 24.8 min for repeat dosing <25 min vs 38.2 min for repeat doses ≥25 min. Repeat dosing of rocuronium 1.2 mg kg−1 after reversal of neuromuscular block by sugammadex 4.0 mg kg−1 in anaesthetized healthy volunteers: a modelling-based pilot study Br J Anaesth. 2010 Oct;105(4):487-92
Ketamine was used by clinical staff from the The Shock Trauma Air Rescue Society (STARS) in Alberta to facilitate intubation in both the pre-hospital & in-hospital setting (with a neuromuscular blocker in only three quarters of cases). Changes in vital signs were small despite the severity of illness in the study population. A prospective review of the use of ketamine to facilitate endotracheal intubation in the helicopter emergency medical services (HEMS) setting Emerg Med J. 2010 Oct 6. [Epub ahead of print]
The prognosis of cirrhotic patients with multiple organ failure is not universally dismal. A retrospective French study examined predictive factors of mortality and concluded: In-hospital survival rate of intensive care unit- admitted cirrhotic patients seemed acceptable, even in patients requiring life-sustaining treatments and/or with multiple organ failure on admission. The most important risk factor for in-hospital mortality was the severity of nonhematologic organ failure, as best assessed after 3 days. A trial of unrestricted intensive care for a few days could be proposed for select critically ill cirrhotic patients. Cirrhotic patients in the medical intensive care unit: Early prognosis and long-term survival Crit Care Med. 2010 Nov;38(11):2108-2116
A single centre observational study of rapid sequence intubation (RSI) was performed in a Scottish Emergency Department (ED) over four and a quarter years, followed by a postal survey of ED RSI operators.
There were 329 RSIs during the study period. RSI was performed by emergency physicians (both trained specialists and training grade, or ‘registrar’ doctors) in 288 (88%) patients. Complication rates were low and there were only two failed intubations requiring surgical airways (0.6%). ED registrars were the predominant RSI operator, with 206 patients (63%). ED consultants performed RSIs on 82 (25%) patients, anaesthetic registrars on 31 (9.4%) patients, and anaesthetic consultants on 8 (2.4%) patients. An ED consultant was present during every RSI performed and an anaesthetist was present during 72 (22%). The average number of ED registrars during this period of training was 8. This equates to each ED trainee performing approximately 26 ED RSIs (6.5 RSIs/year). On average, ED consultants performed 14 RSIs during this period (approx 3.5 RSIs/year). Of the 17 questionnaires, 12 were completed, in all of which cases the trainees were confident to perform RSI independently at the end of registrar training. Interestingly, 45 (14%) of the RSIs in the study were done in the pre-hospital environment by ED staff, two thirds of which were done by ED consultants. Training and competency in rapid sequence intubation: the perspective from a Scottish teaching hospital emergency department Emerg Med J. 2010 Sep 15. [Epub ahead of print]
Central lines in the ED are more likely to get infected because they’re inserted under less scrupulously aseptic conditions than in ICU, done more urgently, and are more likely to be placed in the mucky old femoral site by clumsy emergency physicians who don’t wash their hands after scratching their arses. Anyway, the intensivists will usually replace them with a ‘more ideal’ line after ICU admission. Right? Well, that’s what’s often taught and assumed to be the case, but a new study from a single centre suggests otherwise. ED-placed central venous catheters (19% of which were femoral) were typically left in for 4 to 5 days. The infection rate was 1.9 per 1,000 catheter-days, similar to that reported for central lines in other ICU case series.
